卵泡期内膜搔刮的提前终止随机对照试验
该随机对照试验纳入200例行GnRH拮抗剂方案IVF/ICSI鲜胚移植的女性,比较卵巢刺激第6至8天内膜活检与对照组的临床妊娠率。因干预组临床流产率更高,试验在第二次预设中期分析后提前终止,临床妊娠率两组无显著差异。
要点
- 卵泡期内膜搔刮未提高临床妊娠率(44% vs 40%,P=0.61)
- 干预组临床流产率显著更高(25% vs 8%,P=0.032),试验因此提前终止
- 因样本量不足(200/360),结局结论不确定,搔刮可能有害
核心结论
- 卵泡期内膜搔刮未增加临床妊娠率,但因安全性问题提前终止,不能得出确定结论。
- 研究者提示卵泡期内膜损伤可能有害,需未来研究进一步关注。
研究设计与样本
- 随机对照试验,三级医院,2014年4月3日至2017年10月8日,1:1分配。
- 共纳入200名行GnRH拮抗剂方案IVF/ICSI并鲜胚移植的女性,每组100人。
- 干预为卵巢刺激第6至8天行pipelle内膜活检,对照为不活检。
主要发现
- 意向性分析临床妊娠率活检组44%对对照组40%,P=0.61,风险差3.6(95%CI -10.1;17.3)。
- 活产率活检组32%对对照组36%,P=0.52。
- 生化妊娠丢失两组相近(10% vs 15%,P=0.49),临床流产活检组显著更高(25% vs 8%,P=0.032)。
- 干预组3%出现操作相关剧烈疼痛,5%出现出血。
- 随机化后6个月内累计活产率(含自然与ART妊娠)两组无显著差异(54% vs 60%,P=0.43)。
关键数值与推荐
- 主要结局为临床妊娠率,次要结局包括生化妊娠率、活产率、早期妊娠丢失、操作疼痛/出血及6个月累计生殖结局。
- 试验在第二次预设中期分析后因干预组临床流产率更高而提前终止,仅纳入200例(原需360例)。
临床怎么用
- 不宜在卵泡期常规开展内膜搔刮以改善ART结局。
- 咨询时需告知可能的临床流产风险增加及操作相关疼痛、出血。
局限性
- 试验提前终止,样本量未达预设360例,无法对结局参数得出确定结论。
- 实用性设计可能限制识别可能受益的特定亚组人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does intentional endometrial injury (scratching) during the follicular phase of ovarian stimulation (OS) increase the clinical pregnancy rate (CPR) in ART? SUMMARY ANSWER: CPR did not vary between the endometrial injury and the control group, but the trial was underpowered due to early termination because of a higher clinical miscarriage rate observed in the endometrial injury arm after a prespecified interim analysis. WHAT IS KNOWN ALREADY: Intentional endometrial injury has been put forward as an inexpensive clinical tool capable of enhancing endometrial receptivity. However, despite its widespread use, the benefit of endometrial scratching remains controversial, with several recent randomized controlled trials (RCTs) being unable to confirm its added value. So far, most research has focused on endometrial scratching during the luteal phase of the cycle preceding the one with embryo transfer (ET), while only a few studies investigated in-cycle injury during the follicular phase of OS. Also, the persistence of a scratch effect in subsequent treatment cycles remains unclear and possible harms have been insufficiently studied. STUDY DESIGN, SIZE, DURATION: This RCT was performed in a tertiary hospital setting between 3 April 2014 and 8 October 2017. A total of 200 women (100 per study arm) undergoing IVF/ICSI in a GnRH antagonist suppressed cycle followed by fresh ET were included. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were randomized with a 1:1 allocation ratio to either undergo a pipelle endometrial biopsy between Days 6 and 8 of OS or to be in the control group.The primary outcome was CPR. Secondary outcomes included biochemical pregnancy rate, live birth rate (LBR), early pregnancy loss (biochemical pregnancy losses and clinical miscarriages), excessive procedure pain/bleeding and cumulative reproductive outcomes within 6 months of the study cycle. MAIN RESULTS AND THE ROLE OF CHANCE: The RCT was stopped prematurely by the trial team after the second prespecified interim analysis raised safety concerns, namely a higher clinical miscarriage rate in the intervention group. The intention-to-treat CPR was similar between the biopsy and the control arm (respectively, 44 versus 40%, P = 0.61, risk difference = 3.6 with 95% confidence interval = -10.1;17.3), as was the LBR (respectively, 32 versus 36%, P = 0.52). The incidence of a biochemical pregnancy loss was comparable between both groups (10% in the intervention group versus 15% in the control, P = 0.49), but clinical miscarriages occurred significantly more frequent in the biopsy group (25% versus 8%, P = 0.032). In the intervention group, 3% of the patients experienced excessive procedure pain and 5% bleeding. The cumulative LBR taking into account all conceptions (spontaneous or following ART) within 6 months of randomization was not significantly different between the biopsy and the control group (54% versus 60%, respectively, P = 0.43). LIMITATIONS, REASONS FOR CAUTION: The trial was stopped prematurely due to safety concerns after the inclusion of 200 of the required 360 patients. Not reaching the predefined sample size implies that definite conclusions on the outcome parameters cannot be drawn. Furthermore, the pragmatic design of the study may have limited the detection of specific subgroups of women who may benefit from endometrial scratching. WIDER IMPLICATIONS OF THE FINDINGS: Intentional endometrial injury during the follicular phase of OS warrants further attention in future research, as it may be harmful. These findings should be taken in consideration together with the growing evidence from other RCTs that scratching may not be beneficial. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by 'Fonds Wetenschappelijk Onderzoek' (FWO, Flanders, Belgium, 11M9415N, 1524417N). None of the authors have a conflict of interest to declare with regard to this study.
引用
- Mackens S, Racca A, Van de Velde H, et al. Follicular-phase endometrial scratching: a truncated randomized controlled trial. Hum Reprod. 2020. PMID: 32372078. doi:10.1093/humrep/deaa018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。